The event, organized in cooperation with Slovenian Pharmaceutical Society, brings together guests from across Europe and focuses on Annex 1 requirements and best practices in contamination-controlled environments. AM. ..
The AFI Symposium is the important conference that has been involving pharmaceutical industry stakeholders internationally for more than 60 years, which is why it is confirmed from year to...
On the occasion of the presentation of the Integrated Report 2024, AM meets its stakeholders at the Limbiate Headquarters. A unique event in which it will be possible to discuss the challenges of the near future. From the...
Pharmaceutical, Biopharmaceutical and Laboratory Technology Industry Forum, celebrates its 11th edition in Madrid. Once again the IFEMA facilities have been chosen, specifically Hall 9. ..
AM is again participating in the Advanced Therapies and Radiopharmaceuticals Conference this year. For several years, AM has supported the field dedicated to the production of innovative biological drugs, such as gene therapy, cell therapy and...
PDA BioManufacturing Conference is a key event in the conference landscape in Europe. Discussions among biologic drug manufacturing professionals and updates on major innovations along with issues...
AM is organizing RTF - Ride The Future day, dedicated to those who face the challenges of biodecontamination in controlled contamination environments every day. In the scenario outlined in Annex 1, biodecontamination...
MaxPotent Pharma Summit 2025 is the premier industry event dedicated to the evolving challenges and advances in the field of high potency active pharmaceutical ingredients (HPAPIs). Since...
Since 2012, Aseptikon has been an integral part of the German congress landscape with its conferences on aseptic production, microbiology, hygiene and other current topics related to the assurance and control of...
AM | Ecolab present the event dedicated to the essential update to ensure the proper application of the Contamination Control Strategy in the cleaning and disinfection processes of classified environments. Register now Agenda Case. ..
The second edition of the day will aim to learn more about the management and analysis of environmental monitoring data trends as a key step in controlling and improving the knowledge of...
The A.I.B.A.T. National Congress is an opportunity for practitioners of the Tissue Banks to exchange views in an attempt to standardize, as far as possible, procedures for donor selection, process,...
For 35 years, CPHI has united the global pharmaceutical supply chain. Each year, the pharmaceutical industry community collaborates at CPHI events around the world to make contacts, collaborate and promote...
Aseptic filling is a major issue in pharmaceutical manufacturing. The PDA event explores all the new trends and solutions to effectively meet regulatory requirements....
Once again this year AFI is organizing the national meeting of Qualified Persons. A unique opportunity to meet and discuss the state of Quality in pharmaceuticals. TBA Registration
From January 21-22, 2026, AM will be meeting you in Paris for Pharmack Europe. In addition to the opportunity to get up close and personal with our Pharmaclean® and Zherox® production lines,...
AM will be present at Clean Lab 2026. The 15th edition of the event will focus on regulations, data integrity, advanced therapy manufacturing, and isolator processes. Our team is ready...
AM is at PharmaTechnica 2026. Our presence brings innovative solutions in biodecontamination and packaging dedicated to material transfer and autoclave sterilization. In our exhibition space. ..
We develop, manufacture and distribute state-of-the-art products and services for contamination control in cleanroom.
Via Isonzo, 1/C 20812 Limbiate (MB) Italy
Tel:+39 02 872892.1 - F. +39 02 872892.00
www.aminstruments.com
info@aminstruments.com
VAT no. 02196040964 - Tax code 09191700153
Cap. Soc. € 1,000,000 i.v. - CCIAA-REA NO. 1278816
© Copyright1990-2026 – AM Instruments Srl – VAT number 02196040964 – Privacy Policy – Cookie Policy
